Fundz

BioXcel Therapeutics Appoints Samir Saleem as President and Secretary

PUBLIC · BTAIQOct 30, 2026

Position

Chief Restructuring Officer

Company

BioXcel Therapeutics

Samir Saleem
United StatesBiotechnologyTherapeuticsBiopharma

Description

On October 30, 2026, Samir Saleem was appointed as President and Secretary of BioXcel Therapeutics. He will continue in his role as Chief Restructuring Officer and will serve as the principal executive officer of the Company. This appointment is effective as of 5:00 p.m

Who to call at BioXcel Therapeutics, and when

A new leader at BioXcel Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day BioXcel Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioXcel Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioXcel Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioXcel Therapeutics

Location

United States

About

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric diseases. The company utilizes its proprietary artificial intelligence platform to identify and advance novel drug candidates. Key products in its pipeline include therapeutics aimed at addressing disorders such as agitation and other neuropsychiatric indications. BioXcel's operations are primarily based in the United States, with its headquarters located in New Haven, Connecticut. The company is also publicly traded on The Nasdaq Capital Market under the symbol BTAI, indicating its size and presence in the capital markets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioXcel Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Matt
Senior decision-maker at this company
••••••••@••••••••

See Matt's verified email →

Subhashish
Senior decision-maker at this company
••••••••@••••••••

See Subhashish's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioXcel Therapeutics's next move

Learn about Strategic plan

BioXcel Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.